EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Adoptive Immunotherapy: A Human Pluripotent Stem Cell Perspective

Gyuhyung Jin, Yun Chang, Jackson Duke Harris, Xiaoping Bao

Cells Tissues Organs · 2023

DOI: 10.1159/000528838 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells Tissues Organs, 2023. Verfasst von Gyuhyung Jin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Davidson School of Chemical Engineering, Purdue University, West Lafayette, Indiana, USA. Hauptthemen laut MEDLINE: Pluripotent Stem Cells, Induced Pluripotent Stem Cells, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 228 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The past decade has witnessed significant advances in cancer immunotherapy, particularly through the adoptive transfer of engineered T cells in treating advanced leukemias and lymphomas. Despite these excitements, challenges remain with scale, cost, and ensuring quality control of engineered immune cells, including chimeric antigen receptor T, natural killer cells, and macrophages. The advent of human pluripotent stem cells (hPSCs), including human embryonic stem cells and induced pluripotent stem cells, has transformed immunotherapy by providing a scalable, off-the-shelf source of any desired immune cells for basic research, translational studies, and clinical interventions. The tractability of hPSCs for gene editing could also generate homogenous, universal cellular products with custom functionality for individual or combinatory therapeutic applications. This review will explore various immune cell types whose directed differentiation from hPSCs has been achieved and recently adapted for translational immunotherapy and feature forward-looking bioengineering techniques shaping the future of the stem cell field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pluripotent Stem CellsInduced Pluripotent Stem CellsNeoplasmsHumansImmunotherapy, AdoptiveKiller Cells, NaturalT-LymphocytesImmunotherapy

Stichwörter der Autor:innen

BioengineeringHuman pluripotent stem cellsImmunoengineeringImmunotherapy

Autor:innen und Institutionen

  • Davidson School of Chemical Engineering, Purdue University, West Lafayette, Indiana, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Jin, G., Chang, Y., Harris, J. D., & Bao, X. (2023). Adoptive Immunotherapy: A Human Pluripotent Stem Cell Perspective. Cells Tissues Organs. https://doi.org/10.1159/000528838

Vancouver

Jin G, Chang Y, Harris JD, Bao X. Adoptive Immunotherapy: A Human Pluripotent Stem Cell Perspective. Cells Tissues Organs. 2023. doi:10.1159/000528838

BibTeX
@article{Jin2023,
  author = {Jin, Gyuhyung and Chang, Yun and Harris, Jackson Duke and Bao, Xiaoping},
  title = {Adoptive Immunotherapy: A Human Pluripotent Stem Cell Perspective},
  journal = {Cells Tissues Organs},
  year = {2023},
  doi = {10.1159/000528838}
}
Kostenlos starten →